PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25380345-0 2015 Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation. rosmarinic acid 0-15 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 57-62 33717416-5 2021 RA treatment increased osteoblast differentiation, cell viability and mineralization in MC3T3-E1 osteoblastic cells on Ti surface during differentiation, upregulating Runx-2 and OPG, but downregulating RANKL. rosmarinic acid 0-2 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 202-207 33717416-6 2021 This study suggest that RA should be applied as an effective functional and therapeutic substance to enhance osseointegration of osteoblast cells by increasing differentiation, mineralization, and bone formation through the RANKL/RANK/OPG pathway during the differentiation in MC3T3-E1 osteoblastic cells on the Ti surface. rosmarinic acid 24-26 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 224-229 25380345-6 2015 Moreover, rosmarinic acid inhibited not only osteoclast formation in cocultures of mouse bone marrow cells and osteoblasts, but also receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastic differentiation in bone marrow-derived macrophages. rosmarinic acid 10-25 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 133-184 25380345-6 2015 Moreover, rosmarinic acid inhibited not only osteoclast formation in cocultures of mouse bone marrow cells and osteoblasts, but also receptor activator of nuclear factor kappa-B ligand (RANKL)-induced osteoclastic differentiation in bone marrow-derived macrophages. rosmarinic acid 10-25 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 186-191 25380345-7 2015 RANKL-induced p38 mitogen-activated protein kinase and the expression of nuclear factor of activated T cell, c-Jun, and c-Fos were inhibited by rosmarinic acid in bone marrow macrophages. rosmarinic acid 144-159 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 0-5 25380345-8 2015 Finally, we confirmed that rosmarinic acid improved bone mass in a soluble RANKL-induced bone loss mouse model. rosmarinic acid 27-42 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 75-80 21724708-8 2011 RESULTS: Rosmarinic acid strongly inhibited RANKL-induced NF-kappaB activation and nuclear factor of activated T cells c1 (NFATc1) nuclear translocation in BMM, and also inhibited RANKL-induced formation of TRAP-positive multinucleated cells. rosmarinic acid 9-24 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 44-49 21724708-8 2011 RESULTS: Rosmarinic acid strongly inhibited RANKL-induced NF-kappaB activation and nuclear factor of activated T cells c1 (NFATc1) nuclear translocation in BMM, and also inhibited RANKL-induced formation of TRAP-positive multinucleated cells. rosmarinic acid 9-24 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 180-185 21724708-10 2011 CONCLUSION: We postulated that rosmarinic acid conferred the inhibitory activity on P. amboinicus for inhibition of osteoclastogenesis via downregulation of RANKL-induced NFATc1 expression. rosmarinic acid 31-46 tumor necrosis factor (ligand) superfamily, member 11 Mus musculus 157-162